Posts by: Patricia Inacio, PhD

COPD, News

A team of GSK researchers recently presented at the European Respiratory Society (ERS) Congress data showing eosinophil levels in the blood may be predictors of exacerbation rates in patients with Chronic ... Read more

September 10, 2014November 6, 2015

Two GSK Phase III Studies of Mepolizumab For Severe Eosinophilic Asthma Show Promise

Asthma, News

A team of researchers at GSK recently presented the results from two-PHASE III Clinical Trials of Mepolizumab, a new humanized IL-5 antagonist monoclonal antibody, for the treatment of severe eosinophilic ... Read more

September 9, 2014November 11, 2015

Novartis Claims Once-Daily Ultibro Breezhaler Beats Seretide in Reducing COPD Flare-ups

COPD, News

For the first time, Novartis presented recent results showing a once-a-day Ultibro® Breezhaler® reduces disease exacerbations, i.e. an increase in disease severity, and improves lung function in patients with moderate-to-severe ... Read more

September 2, 2014November 11, 2015

Data on Boehringer Ingelheim’s COPD, Asthma & IPF Therapies to Be Presented At Upcoming Conference

Asthma, COPD, News

According to the American Lung Association, more than 33 million people suffer from chronic lung disease, with Asthma and Chronic Obstructive Pulmonary Disease (COPD) being the most common conditions. Boehringer Ingelheim has a ... Read more